Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Solid Cancers

Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue

Bone Marrow Transplantation volume 52, pages 711–716 (2017)Cite this article

Subjects

Abstract

High-dose therapy and hematopoietic stem cell transplantation (HSCT) have been shown to improve survival rates in high-risk neuroblastoma (HR-NBL), but may cause adverse effects on the growing skeleton. We studied skeletal health in a national cohort of long-term survivors of HR-NBL (n=21; age 16–30 years, median 22 years) and in 20 healthy age- and sex-matched controls. In addition to clinical evaluation and measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry, we performed spinal magnetic resonance imaging. Skeletal complications were categorized according to Common Terminology Criteria for Adverse Events (CTCAE). Altogether, 18/21 survivors presented with at least one skeletal adverse event according to CTCAE, the most common skeletal complications being short stature (n=14) and osteopenia (n=13). Altogether, 38% of the subjects had a severe complication (CTCAE score ⩾3) including bilateral slipped capital femoral epiphyseolysis in 3/21. Fracture rate was not increased. In spinal MRI, no vertebral fractures were found and degenerative intervertebral disc changes were equally prevalent in survivors and controls. BMD was lower in survivors than controls, but differences became non-significant when adjusted for bone size. In conclusion, skeletal late complications are common and can significantly impair the quality of life in young adult survivors of HR-NBL treated with high-dose protocols and HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009; 27: 289–297.

    Article  Google Scholar 

  2. Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015; 33: 3008–3017.

    Article  CAS  Google Scholar 

  3. Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR . Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 2008; 121: e705–e713.

    Article  Google Scholar 

  4. Wilson CL, Ness KK . Bone mineral density deficits and fractures in survivors of childhood cancer. Curr Osteoporos Rep 2013; 11: 329–337.

    Article  Google Scholar 

  5. Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R et al. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res 1999; 14: 2002–2009.

    Article  CAS  Google Scholar 

  6. Kelly J, Damron T, Grant W, Anker C, Holdridge S, Shaw S et al. Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol 2005; 27: 248–253.

    Article  Google Scholar 

  7. Bilariki K, Anagnostou E, Masse V, Elie C, Grill J, Valteau-Couanet D et al. Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivors. Horm Res Paediatr 2010; 74: 319–327.

    Article  CAS  Google Scholar 

  8. den Hoed MA, Klap BC, te Winkel ML, Pieters R, van Waas M, Neggers SJ et al. Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer. Osteoporos Int 2015; 26: 521–529.

    Article  CAS  Google Scholar 

  9. Al-Tonbary YA, El-Ziny MA, Elsharkawy AA, El-Hawary AK, El-Ashry R, Fouda AE . Bone mineral density in newly diagnosed children with neuroblastoma. Pediatr Blood Cancer 2011; 56: 202–205.

    Article  Google Scholar 

  10. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996; 11: 1774–1783.

    Article  CAS  Google Scholar 

  11. van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM . Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002; 141: 204–210.

    Article  Google Scholar 

  12. Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G . Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer 2007; 48: 21–27.

    Article  Google Scholar 

  13. Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM et al. Incident vertebral fractures in children with leukemia during the four years following diagnosis. J Clin Endocrinol Metab 2015; 100: 3408–3417.

    Article  CAS  Google Scholar 

  14. Toiviainen-Salo S, Markula-Patjas K, Kerttula L, Soini I, Valta H, Mäkitie O . The thoracic and lumbar spine in severe juvenile idiopathic arthritis: magnetic resonance imaging analysis in 50 children. J Pediatr 2012; 160: 140–146.

    Article  Google Scholar 

  15. Gawade PL, Hudson MM, Kaste SC, Neglia JP, Wasilewski-Masker K, Constine LS et al. A systematic review of selected musculoskeletal late effects in survivors of childhood cancer. Curr Pediatr Rev 2014; 10: 249–262.

    Article  Google Scholar 

  16. Wilhelmsson M, Vatanen A, Borgström B, Gustafsson B, Taskinen M, Saarinen-Pihkala UM et al. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up. Bone Marrow Transplant 2015; 50: 850–857.

    Article  CAS  Google Scholar 

  17. Vatanen A, Sarkola T, Ojala TH, Turanlahti M, Jahnukainen T, Saarinen-Pihkala UM et al. Radiotherapy-related arterial intima thickening and plaque formation in childhood cancer survivors detected with very-high resolution ultrasound during young adulthood. Pediatr Blood Cancer 2015; 62: 2000–2006.

    Article  CAS  Google Scholar 

  18. Saarinen-Pihkala UM, Hovi L, Koivusalo A, Jahnukainen K, Karikoski R, Sariola H et al. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma. Pediatr Blood Cancer 2012; 59: 1190–1197.

    Article  Google Scholar 

  19. Saarinen UM, Wikström S, Mäkipernaa, Lanning M, Perkkiö M, Hovi L et al. In vivo purging of bone marrow in children with poor risk neuroblastoma for marrow collection and autologous bone marrow transplantation. J Clin Oncol 1996; 14: 2791–2802.

    Article  CAS  Google Scholar 

  20. Carter DR, Bouxsein ML, Marcus R . New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992; 7: 137–145.

    Article  CAS  Google Scholar 

  21. Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom 2014; 17: 225–242.

    Article  Google Scholar 

  22. Vatanen A, Hou M, Huang T, Söder O, Jahnukainen T, Kurimo M et al. Clinical and biological markers of premature aging after autologous SCT in childhood cancer. Bone Marrow Transplant. 2016 in press.

  23. Cohen LE, Gordon JH, Popovsky EY, Gunawardene S, Duffey-Lind E, Lehmann LE et al. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems. Bone Marrow Transplant 2014; 49: 502–508.

    Article  CAS  Google Scholar 

  24. Hobbie WL, Moshang T, Carlson CA, Goldmuntz E, Sacks N, Goldfarb SB et al. Late effect in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma. Pediatr Blood Cancer 2008; 51: 679–683.

    Article  Google Scholar 

  25. Perwein T, Lackner H, Sovinz P, Benesch M, Schmidt S, Schwinger W et al. Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer 2011; 57: 629–635.

    Article  Google Scholar 

  26. Gafni RI, Baron J . Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 2004; 144: 253–257.

    Article  Google Scholar 

  27. Vatanen A, Sarkola T, Ojala TH, Turanlahti M, Jahnukainen T, Saarinen-Pihkala UM et al. Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT. Bone Marrow Transplant 2016; 51: 853–855.

    Article  CAS  Google Scholar 

  28. Wilson CL, Dilley K, Ness KK, Leisenring WL, Sklar CA, Kaste SC et al. Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2012; 118: 5920–5928.

    Article  Google Scholar 

  29. Gholve PA, Cameron DB, Millis MB . Slipped capital femoral epiphysis update. Curr Opin Pediatr 2009; 21: 39–45.

    Article  Google Scholar 

  30. Mostoufi-Moab S, Isaacoff EJ, Spiegel D, Gruccio D, Ginsberg JP, Hobbie W et al. Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy. Pediatr Blood Cancer 2013; 60: 1766–1771.

    Article  Google Scholar 

  31. Laverdière C, Liu Q, Yasui Y, Nathan PC, Gurney JG, Stovall M et al. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009; 101: 1131–1140.

    Article  Google Scholar 

  32. Ishii E, Yoshida N, Miyazaki S . Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy. Eur J Pediatr 1984; 143: 152–153.

    Article  CAS  Google Scholar 

  33. Citron ND, Paterson FW, Jackson AM . Neuropathic osteonecrosis of the lateral femoral condyle in childhood. A report on four cases. J Bone Joint Surg Br 1986; 68: 96–99.

    Article  CAS  Google Scholar 

  34. Geetha N, Kumary PK, Ramachandran K, Nair MK . Avascular necrosis of the femoral head in neuroblastoma: a case report. Pediatr Hematol Oncol 1998; 15: 443–446.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs Päivi Lähteenmäki, Merja Möttönen, Pekka Riikonen and Katriina Parto for identifying the long-term survivors of HR-NBL in local hospital records. The study was funded by Sigrid Juselius Foundation, Swedish Childhood Cancer Foundation, Finnish Cancer Society, the Finnish Foundation for Pediatric Research, the Väre Foundation for Pediatric Cancer Research, the Academy of Finland, Folkhälsan Research Foundation, Helsinki University Hospital Research Funds, Swedish Research Council and Novo Nordisk Foundation.

Author information

Authors and Affiliations

  1. Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    P Utriainen, A Vatanen, U Saarinen-Pihkala, O Mäkitie & K Jahnukainen

  2. Department of Women’s and Children’s Health, Karolinska Institutet and University Hospital, Stockholm, Sweden

    P Utriainen & K Jahnukainen

  3. HUS Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    S Toiviainen-Salo

  4. Folkhälsan Research Center, Helsinki, Finland

    O Mäkitie

  5. Center for Molecular Medicine, Karolinska Institutet and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden

    O Mäkitie

Authors
  1. P Utriainen
    View author publications

    Search author on:PubMed Google Scholar

  2. A Vatanen
    View author publications

    Search author on:PubMed Google Scholar

  3. S Toiviainen-Salo
    View author publications

    Search author on:PubMed Google Scholar

  4. U Saarinen-Pihkala
    View author publications

    Search author on:PubMed Google Scholar

  5. O Mäkitie
    View author publications

    Search author on:PubMed Google Scholar

  6. K Jahnukainen
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to P Utriainen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Utriainen, P., Vatanen, A., Toiviainen-Salo, S. et al. Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue. Bone Marrow Transplant 52, 711–716 (2017). https://doi.org/10.1038/bmt.2016.345

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/bmt.2016.345

This article is cited by

Search

Advanced search

Quick links